Pneumonita de hipersensibilitate – actualități conceptuale

Diana Calaras

Autori

Diana Calaras Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“ https://orcid.org/0000-0002-8963-459X

Cuvinte cheie:

antigeni, expunere, inflamație, fibroză

Rezumat

Pneumonita de hipersensibilitate (PH) este o boală pulmonară interstițială complexă cauzată de inhalarea cronică a unei varietăți de antigene la persoanele susceptibile și sensibilizate, asociată de regulă cu un mediu habitual sau profesional. Acest articol abordează dificultățile ce țin de diagnostic datorate tabloului clinic variat și a spectrului larg de antigene cauzale, evidențiază avantajele metodelor diagnostice utilizate în conformitate cu ultimele recomandări ale ghidurilor de specialitate, precum și provocările ce țin de tratamentul pneumonitei de hipersensibilitate.

Referințe

1. Vasakova, M., Morell, F., Walsh, S., et al. Hypersensitivity Pneumonitis: Perspectives in Diagnosis and Management. In: Am J Respir Crit Care Med, 2017; 196(6): p. 680-689. https://doi.org/10.1164/rccm.201611-2201PP

2. Campbell JM. Acute symptoms following work with hay. In: BMJ, 1932; 2: p. 1143-1144.

3. Nogueira, R., Melo, N., Novais, E.B.H., et al.Hypersensitivity pneumonitis: Antigen diversity and disease implications. In: Pulmonology, 2019; 25(2): p. 97-108. https://doi.org/10.1016/j.pulmoe.2018.07.003

4. Sullivan, A., Shrestha, P., Lanham, T., et al. Bird Fancier's lung: An underdiagnosed etiology of dyspnea. In: Respir Med Case Rep, 2020; 31: p. 101288. https://doi.org/10.1016/j.rmcr.2020.101288

5. Quirce, S., Vandenplas, O., Campo, P., et al. Occupational hypersensitivity pneumonitis: an EAACI position paper. In: Allergy, 2016; 71(6): p. 765-79. https://doi.org/10.1111/all.12866

6. Raghu G, M, R.-J., J., R.C., et al.Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. In: Am J Respir Crit Care Med, 2020; 202(3): p. e36-e69.

7. Selman M, Pardo A, King T E Jr. Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. In: Am J Respir Crit Care Med, 2012; 186(4): p. 314-24. https://doi.org/10.1164/rccm.201203-0513CI

8. Fernandez Perez, E.R., Travis, W.D., Lynch, D.A., et al. Executive Summary: Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Panel Report. In: Chest, 2021; 160(2): p. 595-615. https://doi.org/10.1016/j.chest.2021.03.067

9. Morell, F., Villar, A., Ojanguren, I., et al. Hypersensitivity Pneumonitis: Challenges in Diagnosis and Management, Avoiding Surgical Lung Biopsy. In: Semin Respir Crit Care Med, 2016; 37(3): p. 395-405. https://doi.org/10.1055/s-0036-1580692

10. Fernandez Perez, E.R., Swigris, J.J., Forssen, A.V., et al. Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. In: Chest, 2013; 144(5): p. 1644-1651. https://doi.org/10.1378/chest.12-2685

11. Fernandez Perez ER, Kong AM, Raimundo K, et al. Epidemiology of hypersensitivity pneumonitis among an insured population in the United States: a claims-based cohort analysis. In: Ann Am Thorac Soc, 2018; 15: p. 460-469. Karakatsani, A., Papakosta, D., Rapti, A., et al. Epidemiology of interstitial lung diseases in Greece. In: Respir Med, 2009; 103(8): p. 1122-9. https://doi.org/10.1513/AnnalsATS.201704-288OC

13. Kornum JB, Christensen S, Grijota M, et al. The incidence of interstitial lung disease 1995-2005: a Danish nationwide population-based study. In: BMC Pulm Med 2008; 8: p. 24. https://doi.org/10.1186/1471-2466-8-24

14. Barber, C.M., Wiggans, R.E., Carder, M., et al. Epidemiology of occupational hypersensitivity pneumonitis; reports from the SWORD scheme in the UK from 1996 to 2015. In: Occup Environ Med, 2017; 74(7): p. 528-530. https://doi.org/10.1136/oemed-2016-103838

15. Rittig, A.H., Hilberg, O., Ibsen, R., et al. Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study. In: ERJ Open Res, 2019; 5(4). https://doi.org/10.1183/23120541.00259-2018

16. Blanc, P.D., Annesi-Maesano, I., Balmes, J.R., et al. The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement. In: Am J Respir Crit Care Med, 2019; 199(11): p. 1312-1334. https://doi.org/10.1164/rccm.201904-0717ST

17. Pereira, C.A., Gimenez, A., Kuranishi, L., et al. Chronic hypersensitivity pneumonitis. In: J Asthma Allergy, 2016; 9: p. 171-181. https://doi.org/10.2147/JAA.S81540

18. Calaraş D. Pneumonita de hipersensibilitate-între dovezi și incertitudini. In: Bulletin of the Academy of Sciences of Moldova, 2019; 32(2): p. 231-239.

19. Fishwick, D. New occupational and environmental causes of asthma and extrinsic allergic alveolitis. In: Clin Chest Med, 2012; 33(4): p. 605-16. https://doi.org/10.1016/j.ccm.2012.07.002

20. Vandenplas, O. Occupational asthma: etiologies and risk factors. In: Allergy Asthma Immunol Res, 2011; 3(3): p. 157-67. https://doi.org/10.4168/aair.2011.3.3.157

21. Lhoumeau Adrien, Pernot Julien, Georges Marjolaine, Devilliers Yann, Dalphin Jean Charles, Camus Philippe, Bonniaud Philippe Hypersensitivity pneumonitis due to isocyanate exposure in an airbag "welder". In: European Respiratory Review, 2012; 21: p. 168-169. https://doi.org/10.1183/09059180.00008811

22. Costabel, U., Miyazaki, Y., Pardo, A., et al. Hypersensitivity pneumonitis. In: Nat Rev Dis Primers, 2020; 6(1): p. 65. https://doi.org/10.1038/s41572-020-0191-z

23. Morell, F., Villar, A., Montero, M.A., et al. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study. In: Lancet Respir Med, 2013; 1(9): p. 685-94. https://doi.org/10.1016/S2213-2600(13)70191-7

24. Salisbury, M.L., Myers, J.L., Belloli, E.A., et al.Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go. In: Am J Respir Crit Care Med, 2017; 196(6): p. 690-699. https://doi.org/10.1164/rccm.201608-1675PP

25. Petnak, T. and Moua, T. Exposure assessment in hypersensitivity pneumonitis: a comprehensive review and proposed screening questionnaire. In: ERJ Open Res, 2020; 6(3). https://doi.org/10.1183/23120541.00230-2020

26. Johannson, K.A., Barnes, H., Bellanger, A.P., et al. Exposure Assessment Tools for Hypersensitivity Pneumonitis. An Official American Thoracic Society Workshop Report. In: Ann Am Thorac Soc, 2020; 17(12): p. 1501-1509. https://doi.org/10.1513/AnnalsATS.202008-942ST

27. Samson, M.H., Vestergaard, J.M., Knudsen, C.S., et al. Serum levels of IgG antibodies against Aspergillus fumigatus and the risk of hypersensitivity pneumonitis and other interstitial lung diseases. In: Scand J Clin Lab Invest, 2021; 81(6): p. 451-453. https://doi.org/10.1080/00365513.2021.1943758

28. Munoz, X., Sanchez-Ortiz, M., Torres, F., et al. Diagnostic yield of specific inhalation challenge in hypersensitivity pneumonitis. In: Eur Respir J, 2014; 44(6): p. 1658-65. https://doi.org/10.1183/09031936.00060714

29. Ishizuka, M., Miyazaki, Y., Tateishi, T., et al. Validation of inhalation provocation test in chronic bird-related hypersensitivity pneumonitis and new prediction score. In: Ann Am Thorac Soc, 2015; 12(2): p. 167-73. https://doi.org/10.1513/AnnalsATS.201408-350OC

30. Fernandez Perez, E.R., Koelsch, T.L., Leone, P.M., et al. Clinical Decision-Making in Hypersensitivity Pneumonitis: Diagnosis and Management. In: Semin Respir Crit Care Med, 2020; 41(2): p. 214-228. https://doi.org/10.1055/s-0040-1701250

31. De Sadeleer, L.J., Hermans, F., De Dycker, E., et al. Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study. In: Eur Respir J, 2020; 55(4). https://doi.org/10.1183/13993003.01983-2019

32. Hamblin, M., Prosch, H. and Vasakova, M. Diagnosis, course and management of hypersensitivity pneumonitis. In: Eur Respir Rev, 2022; 31(163). https://doi.org/10.1183/16000617.0169-2021

33. Chung, J.H., Montner, S.M., Adegunsoye, A., et al. CT findings associated with survival in chronic hypersensitivity pneumonitis. In: Eur Radiol, 2017; 27(12): p. 5127-5135. https://doi.org/10.1007/s00330-017-4936-3

34. Salisbury, M.L., Gross, B.H., Chughtai, A., et al. Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis. In: Eur Respir J, 2018; 52(2). https://doi.org/10.1183/13993003.00443-2018

35. Chami, H.A., Diaz-Mendoza, J., Chua, A., et al. Transbronchial Biopsy and Cryobiopsy in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease. In: Ann Am Thorac Soc, 2021; 18(1): p. 148-161. https://doi.org/10.1513/AnnalsATS.202005-421OC

36. Kitaichi M, Shimizu S, Tamaya M, Takaki M, Inoue Y. , ed. Pathology of hypersensitivity pneumonitis. Clinical focus series, hypersensitivity pneumonitis, ed. Sharma OP. 2013, Jaypee Brothers Medical Publishers: New Delhi, India. 22-32. https://doi.org/10.5005/jp/books/12031_3

37. Gaxiola, M., Buendia-Roldan, I., Mejia, M., et al. Morphologic diversity of chronic pigeon breeder's disease: clinical features and survival. In: Respir Med, 2011; 105(4): p. 608-14. https://doi.org/10.1016/j.rmed.2010.11.026

38. Murin, S., Bilello, K.S. and Matthay, R. Other smokingaffected pulmonary diseases. In: Clin Chest Med, 2000; 21(1): p. 121-37, ix. https://doi.org/10.1016/S0272-5231(05)70012-5

39. Warren, C.P. Extrinsic allergic alveolitis: a disease commoner in non-smokers. In: Thorax, 1977; 32(5): p. 567-9. https://doi.org/10.1136/thx.32.5.567

40. Nishida, T., Kawate, E., Ishiguro, T., et al.Antigen avoidance and outcome of nonfibrotic and fibrotic hypersensitivity pneumonitis. In: ERJ Open Res, 2022; 8(1). https://doi.org/10.1183/23120541.00474-2021

41. Akashi, T., Takemura, T., Ando, N., et al. Histopathologic analysis of sixteen autopsy cases of chronic hypersensitivity pneumonitis and comparison with idiopathic pulmonary fibrosis/usual interstitial pneumonia. In: Am J Clin Pathol, 2009; 131(3): p. 405-15. https://doi.org/10.1309/AJCPNWX4SLZRP9SW

42. Salisbury, M.L., Gu, T., Murray, S., et al. Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory In: Chest, 2019; 155(4): p. 699-711. https://doi.org/10.1016/j.chest.2018.08.1076

43. Chung, J.H., Zhan, X., Cao, M., et al. Presence of Air Trapping and Mosaic Attenuation on Chest Computed Tomography Predicts Survival in Chronic Hypersensitivity Pneumonitis. In: Ann Am Thorac Soc, 2017; 14(10): p. 1533-1538. https://doi.org/10.1513/AnnalsATS.201701-035OC

44. Oliveira, R.K.F., Ota-Arakaki, J.S., Gomes, P.S., et al. Pulmonary haemodynamics and mortality in chronic hypersensitivity pneumonitis. In: Eur Respir J, 2018; 51(6). https://doi.org/10.1183/13993003.00430-2018

45. Ojanguren, I., Morell, F., Ramon, M.A., et al. Long-term outcomes in chronic hypersensitivity pneumonitis. In: Allergy, 2019; 74(5): p. 944-952. https://doi.org/10.1111/all.13692

46. Cano-Jiménez E, Rubal D, Pérez de Llano LA, Mengual N, Castro-Añón O, Méndez L, et al. . Farmer's lung disease: analysis of 75 cases. In: Med Clin., 2017; 149: p. 429-35. https://doi.org/10.1016/j.medcle.2017.10.009

47. Adegunsoye, A., Oldham, J.M., Fernandez Perez, E.R., et al. Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis. In: ERJ Open Res, 2017; 3(3). https://doi.org/10.1183/23120541.00016-2017

48. Morisset J. Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis. In: Chest, 2017; 151: p. 619-625. https://doi.org/10.1016/j.chest.2016.10.029

49. Flaherty, K.R., Wells, A.U., Cottin, V., et al. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. In: N Engl J Med, 2019; 381(18): p. 1718-1727. https://doi.org/10.1056/NEJMoa1908681

50. Shibata, S., Furusawa, H. and Inase, N. Pirfenidone in chronic hypersensitivity pneumonitis: a real-life experience. In: Sarcoidosis Vasc Diffuse Lung Dis, 2018; 35(2): p. 139-142.